---
figid: PMC8850794__gr1
figtitle: PI3K/Akt/mTOR pathway in lung cancer; oncogenic alterations, therapeutic
  opportunities, challenges, and a glance at the application of nanoparticles
organisms:
- Mus musculus
- Rattus norvegicus
- Nicotiana tabacum
- Salvia rosmarinus
- Homo sapiens
pmcid: PMC8850794
filename: gr1.jpg
figlink: /pmc/articles/PMC8850794/figure/fig0001/
number: F1
caption: An overview of the PI3K/Akt/mTOR signaling pathway. The PI3K axis is initiated
  by the interaction of a ligand with an RTK that results in the separation of p110α
  (the catalytic subunit) from p85 (the regulatory subunit). An alternative way is
  the activation of a GPCR. After the initiation step, p110α catalyzes the conversion
  of PIP2 to PIP3. Upon PIP3 generation, this molecule per se could phosphorylate
  Akt directly and/or recruit the PDK1. Then, PDK1 and mTORC1 mediate the phosphorylation
  and activation of Akt together. By activating mTOR and consequently S6K, Akt could
  stimulate cell growth. This kinase inhibits FOXO1 and activates NF-κB which therefore
  suppresses the apoptosis process. Moreover, Akt could inhibit the function of p53
  indirectly via activating MDM2. On the other hand, PTEN suppresses the PIP3-dependent
  processes and consequently restricts cell survival, growth, and proliferation.
papertitle: The PI3K/Akt/mTOR pathway in lung cancer; oncogenic alterations, therapeutic
  opportunities, challenges, and a glance at the application of nanoparticles.
reftext: Mohammad-Javad Sanaei, et al. Transl Oncol. 2022 Apr;18:101364.
year: '2022'
doi: 10.1016/j.tranon.2022.101364
journal_title: Translational Oncology
journal_nlm_ta: Transl Oncol
publisher_name: Neoplasia Press
keywords: Lung cancer | Phosphatidyl inositol 3-kinase | PI3K/Akt/mTOR pathway | Drug
  resistance | Adverse event | Nanomedicine
automl_pathway: 0.9481643
figid_alias: PMC8850794__F1
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
redirect_from: /figures/PMC8850794__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8850794__gr1.html
  '@type': Dataset
  description: An overview of the PI3K/Akt/mTOR signaling pathway. The PI3K axis is
    initiated by the interaction of a ligand with an RTK that results in the separation
    of p110α (the catalytic subunit) from p85 (the regulatory subunit). An alternative
    way is the activation of a GPCR. After the initiation step, p110α catalyzes the
    conversion of PIP2 to PIP3. Upon PIP3 generation, this molecule per se could phosphorylate
    Akt directly and/or recruit the PDK1. Then, PDK1 and mTORC1 mediate the phosphorylation
    and activation of Akt together. By activating mTOR and consequently S6K, Akt could
    stimulate cell growth. This kinase inhibits FOXO1 and activates NF-κB which therefore
    suppresses the apoptosis process. Moreover, Akt could inhibit the function of
    p53 indirectly via activating MDM2. On the other hand, PTEN suppresses the PIP3-dependent
    processes and consequently restricts cell survival, growth, and proliferation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - 4933425B07Rik
  - Bas
  - Pten
  - Akt1
  - Mdm2
  - Trp53
  - Foxo1
  - Nfkb1
  - ras
  - Hras
  - Kras
  - Rem1
  - Scn10a
  - Mtor
  - Gpbar1
  - Pik3r1
  - BAS
  - PTEN
  - AKT1
  - AKT2
  - AKT3
  - MDM2
  - TP53
  - TP63
  - TP73
  - FOXO1
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - KRAS
  - HRAS
  - NRAS
  - SCN10A
  - MTOR
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - Tp53
  - Ccne1
  - Rela
  - Tas2r134
  - Rxfp2
  - Pik3cg
---
